Georges J. F. K枚hler, Ph.D.
Brief Bio
Georges Jean Franz K枚hler was born on April 17, 1946, in Munich, Germany. He received his Ph.D. in biology from the University of Freiburg in 1974 before accepting a two-year postdoctoral fellowship at Milstein's lab at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England. In 1976, K枚hler moved to Switzerland where he continued his research at the Basel Institute for 后宫导航, returning to Germany in 1985 as director of the Max Planck Institute for Immune Biology in Freiburg.
K枚hler was only 28 when he devised the hybridoma technique with C茅sar Milstein. Although he designed and carried out the experiment, his stature was often overshadowed by that of Milstein, already a renowned immunologist. The significance of his role in developing hybridomas was fully recognized only as recently as 1984 when he received both the Lasker Award and Nobel Prize with Milstein. A quiet, modest man, K枚hler never objected to Milstein's greater prominence. In a 1981 memorandum describing his role in the development of the technique, he wrote, "I believe I was the driving force in it, but it is also true to say that I would not have thought about this problem in any other laboratory than C茅sar Milstein's and I wouldn't have been encouraged to do the experiment by anyone else but C茅sar Milstein."
K枚hler died of a heart attack on March 1, 1995, in Freiburg, Germany. He was 48.
Nobel Prize in Physiology or Medicine
1984 Nobel Prize in Physiology or Medicine with
C茅sar Milstein (AAI '79) and
Niels Jerne (AAI '73) “for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies.”
Lasker Award
1984 Albert Lasker Basic Medical Research Award “for his imaginative concepts and painstaking experiments which produced the first hybridoma and made possible monoclonal antibody technology.” for more details.
AAI Service History
Joined: 1985
Nobel Prize in Science
Georges J. F. K枚hler was awarded the 1984 Nobel Prize for Physiology or Medicine, jointly with his mentor, C茅sar Milstein (AAI '79), and the famed theoretician in immunology, Niels Jerne (AAI '73). Milstein and K枚hler were given the award for developing the hybridoma technique for producing monoclonal antibodies.
Before K枚hler and Milstein developed the hybridoma technique in 1974, scientists could not efficiently produce specific antibodies because of the difficulty of cultivating plasma cells in the laboratory. Tumor cells, on the other hand, were more amenable to continuous culture: by the mid-1960s, Michael Potter had demonstrated that malignant plasma cells, called myelomas, could replicate and produce immunoglobulins indefinitely in culture. K枚hler hypothesized that it might be possible to create a hybrid cell by fusing spleen cells to myelomas. With Milstein's encouragement, K枚hler carried out this fusion experiment and created the first hybridomas. Each hybridoma had the proliferative capability of the myeloma cell but was able to produce an antibody clone originating from the spleen cell. In short, K枚hler had discovered a method of creating immortalized cell lines with an unlimited capacity to produce a specific monoclonal antibody.
K枚hler continued to refine his method of producing monoclonal antibodies throughout his career. He went on to identify myelomas that would allow for the production of antibody clones originating from only the spleen cell with which it was fused, describing one such cell line, Sp2/0-Ag14, in 1978. In the 1980s and 1990s, while at the Max Planck Institute, he expanded his studies to elucidate mechanisms of immunoglobulin expression and B cell development, and he also explored the effects of cytokines on immune responses through the development of various knockout mice.
"Since Dr. K枚hler and Dr. Milstein first described their method of making monoclonal antibodies, every area of biomedical investigation has benefited," announced the jury that awarded the immunologists the 1984 Albert Lasker Basic Medical Research Award. Monoclonal antibodies have enabled researchers to characterize previously unknown types of lymphocytes; refine tests for infectious diseases; elucidate the mechanisms behind thyroid disorders, autoimmune diseases, and inherited brain disorders; reduce drug toxicity; identify metastasized cancer in the body; and suppress rejection in organ transplants.
Awards and Honors
Institutional/Biographical Links
- Nobel Prize
- New York Times